azauracil has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FREI, E; FREIREICH, EJ; GEHAN, EA; HAURANI, F; HOLLAND, JF; PINKEL, D; ROTHBERG, H; SELAWRY, O; TAYLOR, R | 1 |
| Gehan, EA | 1 |
2 other study(ies) available for azauracil and Acute Disease
| Article | Year |
|---|---|
Evaluation of a new chemotherapeutic agent in patients with 'advanced refractory' acute leukemia. Studies of 6-azauracil.
Topics: Acute Disease; Antineoplastic Agents; Humans; Leukemia; Uracil | 1960 |
Design of controlled clinical trials: use of historical controls.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Glioma; Humans; Leukemia; Male; Plicamycin; Random Allocation; Uracil; Vincristine | 1982 |